DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
18F-FSPG
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
18F-FSPG
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRAPIPRANT
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Osteoarthritis
Prostanoid EP4 receptor antagonist
GRAPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
J9F5ZPH7NB
Molecule Type:
Small molecule
Molecular Formula:
C26H29N5O3S
Molecular Weight:
491.62
AlogP:
4.14
PSA:
105.98
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CARBOXYMETHYLCELLULOSE CALCIUM
2
Unknown
Investigational
Unknown
Unknown
Conjunctivitis, Viral
Unknown
CARBOXYMETHYLCELLULOSE CALCIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
UTY7PDF93L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALDAFERMIN
2
Protein
Investigational
Unknown
Unknown
Constipation; Kidney Diseases; Liver Diseases; Cholangitis, Sclerosing; Diabetes Mellitus; Liver Cirrhosis, Biliary; Non-alcoholic Fatty Liver Disease
Unknown
ALDAFERMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
IK9NYN31ZM
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMPOL
2
Small molecule
Investigational
Unknown
Unknown
Anus Neoplasms; Cardiovascular Diseases; Alopecia; Glioblastoma; Prostatic Neoplasms, Castration-Resistant; Severe Acute Respiratory Syndrome
Unknown
TEMPOL
×
Maximum Phase:
2
First Approval:
None
UNII:
U78ZX2F65X
Molecule Type:
Small molecule
Molecular Formula:
C9H18NO2
Molecular Weight:
172.25
AlogP:
1.35
PSA:
43.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GUSACITINIB
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Dermatitis; Dermatitis, Atopic
Janus Kinase (JAK) inhibitor
GUSACITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
4801QYW816
Molecule Type:
Small molecule
Molecular Formula:
C24H28N8O2
Molecular Weight:
460.54
AlogP:
2.55
PSA:
134.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LURTOTECAN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma
Unknown
LURTOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
4J1L80T08I
Molecule Type:
Small molecule
Molecular Formula:
C28H30N4O6
Molecular Weight:
518.57
AlogP:
1.6
PSA:
106.36
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AKN-028
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
AKN-028
×
Maximum Phase:
2
First Approval:
None
UNII:
Y66IS3CS0R
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AXOMADOL
2
Small molecule
Investigational
Unknown
Unknown
Chronic Pain; Pain; Low Back Pain
Delta opioid receptor agonist
AXOMADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
9J92U4CVS0
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO3
Molecular Weight:
279.38
AlogP:
1.61
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RHEUM PALMATUM ROOT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RHEUM PALMATUM ROOT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DESLORELIN
2
Protein
Investigational
Unknown
Unknown
Growth Disorders; Hereditary Breast and Ovarian Cancer Syndrome; Puberty, Precocious
Unknown
DESLORELIN
×
Maximum Phase:
2
First Approval:
None
UNII:
TKG3I66TVE
Molecule Type:
Protein
Molecular Formula:
C64H83N17O12
Molecular Weight:
1282.47
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GTI-2040
2
Unknown
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms, Male; Leukemia, Myeloid, Acute; Prostatic Neoplasms, Castration-Resistant
Ribonucleotide reductase small subunit mRNA antisense inhibitor
GTI-2040
×
Maximum Phase:
2
First Approval:
None
UNII:
5WY0FWR2CF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFATUTAZONE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
EFATUTAZONE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
76B44WEA8O
Molecule Type:
Small molecule
Molecular Formula:
C27H28Cl2N4O4S
Molecular Weight:
575.52
AlogP:
5.04
PSA:
108.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
T-817 MALEATE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Alzheimer Disease; Cognitive Dysfunction
Unknown
T-817 MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
0LB9F7I5P3
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO6S
Molecular Weight:
407.49
AlogP:
2.53
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CARBASALATE CALCIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CARBASALATE CALCIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OPIGOLIX
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Endometriosis
Gonadotropin-releasing hormone receptor antagonist
OPIGOLIX
×
Maximum Phase:
2
First Approval:
None
UNII:
VQ6CK0CITA
Molecule Type:
Small molecule
Molecular Formula:
C25H19F3N4O5S
Molecular Weight:
544.51
AlogP:
3.56
PSA:
148.45
HBD:
5.0
HBA:
#RotB:
7.0
Source:
ABX-IL8
2
Antibody
Investigational
Unknown
Unknown
Bronchitis, Chronic
Interleukin-8 inhibitor
ABX-IL8
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAZODALIBEP
2
Protein
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
CD40 ligand antagonist
DAZODALIBEP
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7160
2
Antibody
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 antagonist
RG-7160
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GOLD
2
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Parkinson Disease
Unknown
GOLD
×
Maximum Phase:
2
First Approval:
None
UNII:
79Y1949PYO
Molecule Type:
Small molecule
Molecular Formula:
Au
Molecular Weight:
196.97
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PF-06650833
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06650833
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VARLILUMAB
2
Antibody
Investigational
Unknown
Unknown
Astrocytoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Lymphoma; Oligodendroglioma; Urogenital Neoplasms; Cholangiocarcinoma; Glioblastoma; Melanoma
CD27 antigen agonist
VARLILUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
0125DUV5XC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIIB059
2
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
C-type lectin domain family 4 member C inhibitor
BIIB059
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG3487
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist
RG3487
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TC99M-MARACICLATIDE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TC99M-MARACICLATIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROSTAFUROXIN
2
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension; Hypertension
Unknown
ROSTAFUROXIN
×
Maximum Phase:
2
First Approval:
None
UNII:
P848LCX62B
Molecule Type:
Small molecule
Molecular Formula:
C23H34O4
Molecular Weight:
374.52
AlogP:
3.99
PSA:
73.83
HBD:
3.0
HBA:
#RotB:
1.0
Source:
POLY-ICLC
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
POLY-ICLC
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAVOCAFTOR
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
NAVOCAFTOR
×
Maximum Phase:
2
First Approval:
None
UNII:
W2F2XU189O
Molecule Type:
Small molecule
Molecular Formula:
C15H11F3N4O5S
Molecular Weight:
416.34
AlogP:
1.94
PSA:
141.43
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CALCITONIN EEL
2
Protein
Investigational
Unknown
Unknown
Hemiplegia
Unknown
CALCITONIN EEL
×
Maximum Phase:
2
First Approval:
None
UNII:
R5527T0R0U
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIXARELIMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Oncostatin-M-specific receptor subunit beta inhibitor
VIXARELIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
W25GO3A75W
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VISNADINE
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases
Unknown
VISNADINE
×
Maximum Phase:
2
First Approval:
None
UNII:
0RL4V0K263
Molecule Type:
Small molecule
Molecular Formula:
C21H24O7
Molecular Weight:
388.42
AlogP:
3.53
PSA:
92.04
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BASIMGLURANT
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major; Fragile X Syndrome
Metabotropic glutamate receptor 5 modulator
BASIMGLURANT
×
Maximum Phase:
2
First Approval:
None
UNII:
3110E3AO8S
Molecule Type:
Small molecule
Molecular Formula:
C18H13ClFN3
Molecular Weight:
325.77
AlogP:
4.08
PSA:
30.71
HBD:
0.0
HBA:
#RotB:
1.0
Source:
EX-527
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EX-527
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C13H15ClN2O
Molecular Weight:
250.73
AlogP:
2.5
PSA:
55.12
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SR-123781A
2
Unknown
Investigational
Unknown
Unknown
Coronary Artery Disease; Venous Thromboembolism
Unknown
SR-123781A
×
Maximum Phase:
2
First Approval:
None
UNII:
V952P6826M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
URELUMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Gliosarcoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Leukemia; Melanoma
Tumor necrosis factor receptor superfamily member 9 agonist
URELUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
230902QLLC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
163
164
165
166
167
168
169
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA